Your email has been successfully added to our mailing list.

×
0 0 0.0044791666666668 1.32169407693471E-16 -0.0104017857142857 -0.0148809523809523 1.32169407693471E-16 -0.0714285714285714
Stock impact report

Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMT [Yahoo! Finance News]

ImmunoGen, Inc. (IMGN) 
Last immunogen, inc. earnings: 5/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.immunogen.com/investor-relations
In particular, looking at the business today, the data we have generated from the Phase III study of mirvetuximab give us a clear view of which patients benefit most from mirvetuximab and how best to identify those patients. This, in turn, gives us confidence that our next studies with mirvetuximab will produce positive outcomes. To this end, we have aligned with FDA that a single-arm study in women with folate receptor alpha high, platinum-resistant ovarian cancer who've been previously treated with Avastin could support accelerated approval. We called this study SORAYA and expect to enroll the first patient this quarter, with top line data anticipated in mid-2021, followed by a BLA submission in the second half of 2021 and a potential approval in 2022. Beyond the first approval, we have ongoing studies to expand the potential indications for mirvetuximab with additional data this year. Our portfolio also includes 3 additional programs targeting a range of tumor types in both hematol Show less Read more
Impact Snapshot
Event Time:
IMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMGN alerts
Opt-in for
IMGN alerts

from News Quantified
Opt-in for
IMGN alerts

from News Quantified